Evidence map›Paper›PMID 32929377›Full record

ArticleTheranostics2020

The ERα-miR-575-p27 feedback loop regulates tamoxifen sensitivity in ER-positive Breast Cancer.

Shu-Shu Liu, Yun Li, Hui Zhang, Di Zhang, Xiao-Bei Zhang, Xin Wang, Yue Yu

Open access · goldAbstract read
In one paragraph

Article in Theranostics, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Article
  9. Article
  10. Obesity as a Risk Factor for Breast Cancer-The Role of miRNA.International journal of molecular sciences · 2022
    Review
  11. Review
  12. ZNF384-ZEB1 feedback loop regulates breast cancer metastasis.Molecular medicine (Cambridge, Mass.) · 2022
    Article
  13. Article
  14. Review
  15. Review
  16. Article
  17. Roles of Nuclear Receptors in Vascular Calcification.International journal of molecular sciences · 2021
    Review
  18. Progress of Breast Cancer basic research in China.International journal of biological sciences · 2021
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Shu-Shu LiuThe First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
Yun LiThe First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
Hui ZhangThe First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
Di ZhangThe First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
Xiao-Bei ZhangKey Laboratory of Cancer Prevention and Therapy, Tianjin 300060, China.
Xin WangThe First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
Yue YuThe First Department of Breast Cancer, Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Tianjin 300060, China.
Tianjin Medical University Cancer Institute and Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBiomarkers, TumorBRCA1 ProteinBreastBreast NeoplasmsCell Line, TumorChemotherapy, AdjuvantCyclin D1Cyclin-Dependent Kinase Inhibitor p27Drug Resistance, NeoplasmEstrogen Receptor alphaFeedback, PhysiologicalFemaleGene Expression Regulation, NeoplasticHumansKaplan-Meier EstimateBiomarkers, TumorBRCA1 ProteinBRCA1 protein, humanCCND1 protein, humanCDKN1B protein, humanCyclin D1Cyclin-Dependent Kinase Inhibitor p27ESR1 protein, humanEstrogen Receptor alphaMicroRNAsMIRN575 microRNA, humanTamoxifenmiR-575 regulates ER+ breast cancer tamoxifen sensitivity

Identifiers

PMID32929377
PMCPMC7482812
OpenAlexW3084097794

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.